CAS: 252870-53-4; (S,E)-5-(5-Isopropoxypyridin-3-yl)-N-Methylpent-4-En-2-Amine

该化合物是一种化学化合物,主要具有选择性的阿尔法-7尼古丁乙酰胆碱受体激动剂的作用;它的潜在治疗应用引起了注意,特别是在治疗阿尔茨海默氏病和...

结构式图片

上下游产品

(2R)-(4E)-5-(5-Isopropoxy-Pyridin-3-yl)-4-Penten-2-Ol 252870-91-0
(2S)-(4E)-N-Methyl-N-(Tert-Butoxycarbonyl)-5-[3-(5-Isopropoxypyridin)Yl]-4-Penten-2-Amine 312728-34-0

合成工艺路线路线简述

    (R)-Pent-4-En-2-Yl 4-Methylbenzenesulfonate置于palladium Diacetate,三(邻甲基苯基)磷 盐酸,水,N,N-二异丙基乙胺体系中,用 四氢呋喃,甲基叔丁基醚,N,N-二甲基乙酰胺,醋酸异丙酯,水 用作溶剂,化学反应 4.25H,反应生成异丙克兰
    参考文献: New Process For The Preparation Of Aryl Substituted Olefinic Amines[fr] Nouveau Procédé Pour La Préparation D'Amines Oléfiniques à Substitution Aryle
    标题: New Process For The Preparation Of Aryl Substituted Olefinic Amines[fr] Nouveau Procédé Pour La Préparation D'Amines Oléfiniques à Substitution Aryle

    海关参考信息

    专利信息


    专利号:EP-4630405-A1
    优先权日:2022-12-06
    标题 :Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels

    专利号:US-9751877-B2
    优先权日:2012-09-21
    标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:WO-2024123815-A1
    优先权日:2022-12-06
    标 题:Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels

    专利号:WO-2012172449-A1
    优先权日:2011-06-13
    标题:Lactams as beta secretase inhibitors
    发明人:BRODNEY MICHAEL AARON
    权利人:PFIZER; BRODNEY MICHAEL AARON
    摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.

    专利号:US-2016229847-A1
    优先权日:2013-10-04
    标 题:Novel bicyclic pyridinones as gamma-secretase modulators
    发明人:PETTERSSON MARTIN YOUNGJIN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; JOHNSON DOUGLAS SCOTT; KAUFFMAN GREGORY WAYNE; O'DONNELL CHRISTOPHER WILLIAM; PATEL NANDINI CHATURBHAI; STEPAN ANTONIA FRIEDERIKE; STIFF CORY MICHAEL; SUBRAMANYAM CHAKRAPANI; TRAN TUAN PHONG; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula II as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-9067934-B2
    优先权日:2011-03-31
    标题 :Bicyclic pyridinones
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; FISH BENJAMIN ADAM; GREEN MICHAEL ERIC; MULLINS PATRICK BRADLEY; STIFF CORY MICHAEL; TRAN TUAN PHONG; NAVARATNAM THAYALAN
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    深圳市百胜科创生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rootbio.com
    电话: 0755-26737815/26017435👤
    📞深圳市百胜科创生物科技有限公司 ⚠️参考联系方式

    销售电话:0755-26737815/26017435
    邮箱:sz@rootbio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Buoli M, Serati M, Cahn W. Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Rev Neurother. 2016;16(2):131-44. doi: 10.1586/14737175.2016.1135735. Review. doi: 10.1016/j.ejps.2014.04.007. doi: 10.1016/j.biopsych.2013.11.024. doi: 10.1016/j.biopsych.2013.06.002. doi: 10.1007/s00213-012-2712-2. doi: 10.1016/j.neulet.2012.02.081. doi: 10.1016/j.schres.2011.10.004. . Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study. J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554. doi: 10.1038/clpt.2010.131. . A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. J Psychopharmacol. 2011 Aug;25(8):1020-9. doi: 10.1177/0269881110367727. doi: 10.1016/j.pain.2010.01.007. Erratum in: J Psychopharmacol. 2008 Aug;22(6):698.

    合成参考文献


    参考文献:10.1007/s00213-011-2393-2
    摘要:Apostol G, Abi-Saab W, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD. Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl). 2012 Feb;219(3):715–25. doi: 10.1007/s00213-011-2393-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知